Intravesical Solution

DRUG3 trials

Sponsors

Ankara Training and Research Hospital, David D'Andrea, Dokuz Eylul University

Conditions

BCGBladder CancerDocetaxelEpirubicin Adverse ReactionGemcitabineIntravesical InstillationSuperficial Bladder CancerTumor Recurrence

Phase 3

Single-Dose Intravesical Chemotherapy After Diagnostic URS

Not yet recruitingNCT05810623

David D'AndreaBladder Cancer, Upper Urinary Tract Urothelial Carcinoma

Start: 2023-06-01End: 2026-12-31Target: 394Updated: 2023-04-12

Unknown Phase

Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation

Ankara Training and Research HospitalBladder Cancer, Epirubicin Adverse Reaction, Superficial Bladder Cancer +1

Start: 2019-10-01End: 2023-11-05Target: 100Updated: 2023-03-28

Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients

Not yet recruitingNCT06374914

Dokuz Eylul UniversityBCG, Bladder Cancer, Docetaxel +2

Start: 2024-04-09End: 2026-04-09Target: 120Updated: 2024-04-19